BeOne Medicines AG (HKG:6160)
188.10
+4.30 (2.34%)
Nov 5, 2025, 9:45 AM HKT
BeOne Medicines AG Employees
BeOne Medicines AG had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
3.26M HKD
Profits / Employee
-126.77K HKD
Market Cap
266.84B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11,000 | 400 | 3.77% |
| Dec 31, 2023 | 10,600 | 1,600 | 17.78% |
| Dec 31, 2022 | 9,000 | 1,000 | 12.50% |
| Dec 31, 2021 | 8,000 | 2,700 | 50.94% |
| Dec 31, 2020 | 5,300 | 1,800 | 51.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 24,379 |
| CSPC Pharmaceutical Group | 21,400 |
| WuXi Biologics | 12,575 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| Innovent Biologics | 5,659 |
| 3SBio | 5,577 |
| JD Health International | 3,564 |
| Akeso | 3,035 |
BeOne Medicines AG News
- 2 months ago - BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up - Benzinga
- 3 months ago - A Glimpse of BeiGene's Earnings Potential - Benzinga
- 3 months ago - BeiGene's Earnings: A Preview - Benzinga
- 3 months ago - BeiGene Q2 2025 Earnings Preview - Seeking Alpha
- 4 months ago - Glenmark Pharmaceuticals launches TEVIMBRA in India for advanced lung and esophageal cancer treatment - Business Upturn
- 5 months ago - Glenmark Pharmaceuticals to launch Zanubrutinib (BRUKINSA) in India after DCGI approval - Business Upturn
- 5 months ago - Cancer Stock Vaults 40% As Clinical Trial Shows 'Promise'; Sales Reach $1 Billion, Earnings To Triple - Investor's Business Daily
- 5 months ago - BeiGene gets EU backing for neck and head cancer treatment - Seeking Alpha